Tumor Seeding

14,000,000 Leading Edge Experts on the ideXlab platform

Scan Science and Technology

Contact Leading Edge Experts & Companies

Scan Science and Technology

Contact Leading Edge Experts & Companies

The Experts below are selected from a list of 4209 Experts worldwide ranked by ideXlab platform

Kei Yane - One of the best experts on this subject based on the ideXlab platform.

  • resected Tumor Seeding in stomach wall due to endoscopic ultrasonography guided fine needle aspiration of pancreatic adenocarcinoma
    World Journal of Gastroenterology, 2015
    Co-Authors: Akiko Tomonari, Akio Katanuma, Tomoaki Matsumori, Hajime Yamazaki, Itsuki Sano, Ryuki Minami, Manabu Senyo, Satoshi Ikarashi, Kei Yane, Kuniyuki Takahashi
    Abstract:

    Endoscopic ultrasonography-guided fine needle aspiration (EUS-FNA) is a useful and relatively safe tool for the diagnosis and staging of pancreatic cancer. However, there have recently been several reports of Tumor Seeding after EUS-FNA of adenocarcinomas. A 78-year-old man was admitted to our hospital due to upper gastric pain. Examinations revealed a 20 mm mass in the pancreatic body, for which EUS-FNA was performed. The cytology of the lesion was adenocarcinoma, and the stage of the cancer was T3N0M0. The patient underwent surgery with curative intent, followed by adjuvant chemotherapy with S-1. An enlarging gastric submucosal Tumor was found on gastroscopy at 28 mo after surgery accompanied by a rising level of CA19-9. Biopsy result was adenocarcinoma, consistent with a pancreatic primary Tumor. Tumor Seeding after EUS-FNA was strongly suspected. The patient underwent surgical resection of the gastric Tumor with curative intent. The pathological result of the resected gastric specimen was adenocarcinoma with a perfectly matched mucin special stain result with the previously resected pancreatic cancer. This is the first case report of Tumor Seeding after EUS-FNA which was surgically resected and inspected pathologically.

  • Resected Tumor Seeding in stomach wall due to endoscopic ultrasonography-guided fine needle aspiration of pancreatic adenocarcinoma
    World journal of gastroenterology, 2015
    Co-Authors: Akiko Tomonari, Akio Katanuma, Tomoaki Matsumori, Hajime Yamazaki, Itsuki Sano, Ryuki Minami, Satoshi Ikarashi, Manabu Sen-yo, Toshifumi Kin, Kei Yane
    Abstract:

    Endoscopic ultrasonography-guided fine needle aspiration (EUS-FNA) is a useful and relatively safe tool for the diagnosis and staging of pancreatic cancer. However, there have recently been several reports of Tumor Seeding after EUS-FNA of adenocarcinomas. A 78-year-old man was admitted to our hospital due to upper gastric pain. Examinations revealed a 20 mm mass in the pancreatic body, for which EUS-FNA was performed. The cytology of the lesion was adenocarcinoma, and the stage of the cancer was T3N0M0. The patient underwent surgery with curative intent, followed by adjuvant chemotherapy with S-1. An enlarging gastric submucosal Tumor was found on gastroscopy at 28 mo after surgery accompanied by a rising level of CA19-9. Biopsy result was adenocarcinoma, consistent with a pancreatic primary Tumor. Tumor Seeding after EUS-FNA was strongly suspected. The patient underwent surgical resection of the gastric Tumor with curative intent. The pathological result of the resected gastric specimen was adenocarcinoma with a perfectly matched mucin special stain result with the previously resected pancreatic cancer. This is the first case report of Tumor Seeding after EUS-FNA which was surgically resected and inspected pathologically.

Akiko Tomonari - One of the best experts on this subject based on the ideXlab platform.

  • resected Tumor Seeding in stomach wall due to endoscopic ultrasonography guided fine needle aspiration of pancreatic adenocarcinoma
    World Journal of Gastroenterology, 2015
    Co-Authors: Akiko Tomonari, Akio Katanuma, Tomoaki Matsumori, Hajime Yamazaki, Itsuki Sano, Ryuki Minami, Manabu Senyo, Satoshi Ikarashi, Kei Yane, Kuniyuki Takahashi
    Abstract:

    Endoscopic ultrasonography-guided fine needle aspiration (EUS-FNA) is a useful and relatively safe tool for the diagnosis and staging of pancreatic cancer. However, there have recently been several reports of Tumor Seeding after EUS-FNA of adenocarcinomas. A 78-year-old man was admitted to our hospital due to upper gastric pain. Examinations revealed a 20 mm mass in the pancreatic body, for which EUS-FNA was performed. The cytology of the lesion was adenocarcinoma, and the stage of the cancer was T3N0M0. The patient underwent surgery with curative intent, followed by adjuvant chemotherapy with S-1. An enlarging gastric submucosal Tumor was found on gastroscopy at 28 mo after surgery accompanied by a rising level of CA19-9. Biopsy result was adenocarcinoma, consistent with a pancreatic primary Tumor. Tumor Seeding after EUS-FNA was strongly suspected. The patient underwent surgical resection of the gastric Tumor with curative intent. The pathological result of the resected gastric specimen was adenocarcinoma with a perfectly matched mucin special stain result with the previously resected pancreatic cancer. This is the first case report of Tumor Seeding after EUS-FNA which was surgically resected and inspected pathologically.

  • Resected Tumor Seeding in stomach wall due to endoscopic ultrasonography-guided fine needle aspiration of pancreatic adenocarcinoma
    World journal of gastroenterology, 2015
    Co-Authors: Akiko Tomonari, Akio Katanuma, Tomoaki Matsumori, Hajime Yamazaki, Itsuki Sano, Ryuki Minami, Satoshi Ikarashi, Manabu Sen-yo, Toshifumi Kin, Kei Yane
    Abstract:

    Endoscopic ultrasonography-guided fine needle aspiration (EUS-FNA) is a useful and relatively safe tool for the diagnosis and staging of pancreatic cancer. However, there have recently been several reports of Tumor Seeding after EUS-FNA of adenocarcinomas. A 78-year-old man was admitted to our hospital due to upper gastric pain. Examinations revealed a 20 mm mass in the pancreatic body, for which EUS-FNA was performed. The cytology of the lesion was adenocarcinoma, and the stage of the cancer was T3N0M0. The patient underwent surgery with curative intent, followed by adjuvant chemotherapy with S-1. An enlarging gastric submucosal Tumor was found on gastroscopy at 28 mo after surgery accompanied by a rising level of CA19-9. Biopsy result was adenocarcinoma, consistent with a pancreatic primary Tumor. Tumor Seeding after EUS-FNA was strongly suspected. The patient underwent surgical resection of the gastric Tumor with curative intent. The pathological result of the resected gastric specimen was adenocarcinoma with a perfectly matched mucin special stain result with the previously resected pancreatic cancer. This is the first case report of Tumor Seeding after EUS-FNA which was surgically resected and inspected pathologically.

Carol R. Bradford - One of the best experts on this subject based on the ideXlab platform.

  • comparison of ultrasound guided core biopsy versus fine needle aspiration biopsy in the evaluation of salivary gland lesions
    Head and Neck-journal for The Sciences and Specialties of The Head and Neck, 2013
    Co-Authors: Nicholas J. Douville, Carol R. Bradford
    Abstract:

    Ultrasound-guided core biopsy provides many benefits compared with fine-needle aspiration cytology and has begun to emerge as part of the diagnostic work-up for a salivary gland lesion. Although the increased potential for Tumor-Seeding and capsule rupture has been extensively discussed, the safety of this procedure is widely accepted based on infrequent reports of Tumor-Seeding. In fact, a review of the literature shows only 2 cases of salivary Tumor Seeding following biopsy with larger-gauge needle characteristics, with 2 reported cases of salivary Tumor Seeding following fine-needle aspiration cytology. However, the follow-up interval of such studies (<7 years) is substantially less than the 20-year follow-up typically necessary to detect remote recurrence. Studies on Tumor recurrence of pleomorphic adenoma, the most common salivary gland lesion, suggest that as many as 16% of Tumor recurrences occur at least 10 years following initial surgery, with average time to recurrence ranging anywhere from 6.1 to 11.8 years postoperatively. Despite the benefits of ultrasound-guided core biopsy over fine-needle aspiration biopsy, which include both improved consistency and diagnostic accuracy, current studies lack adequate patient numbers and follow-up duration to confirm comparable safety profile to currently accepted fine-needle aspiration cytology. In this report we: (1) compare the relative benefits of each procedure, (2) review evidence regarding Tumor Seeding in each procedure, (3) discuss time course and patient numbers necessary to detect Tumor recurrence, and (4) describe how these uncertainties should be factored into clinical considerations. © 2012 Wiley Periodicals, Inc. Head Neck, 35: 1657–1661, 2013

  • Comparison of ultrasound-guided core biopsy versus fine-needle aspiration biopsy in the evaluation of salivary gland lesions.
    Head & neck, 2012
    Co-Authors: Nicholas J. Douville, Carol R. Bradford
    Abstract:

    Ultrasound-guided core biopsy provides many benefits compared with fine-needle aspiration cytology and has begun to emerge as part of the diagnostic work-up for a salivary gland lesion. Although the increased potential for Tumor-Seeding and capsule rupture has been extensively discussed, the safety of this procedure is widely accepted based on infrequent reports of Tumor-Seeding. In fact, a review of the literature shows only 2 cases of salivary Tumor Seeding following biopsy with larger-gauge needle characteristics, with 2 reported cases of salivary Tumor Seeding following fine-needle aspiration cytology. However, the follow-up interval of such studies (

Arthur D. Smith - One of the best experts on this subject based on the ideXlab platform.

Kuniyuki Takahashi - One of the best experts on this subject based on the ideXlab platform.

  • resected Tumor Seeding in stomach wall due to endoscopic ultrasonography guided fine needle aspiration of pancreatic adenocarcinoma
    World Journal of Gastroenterology, 2015
    Co-Authors: Akiko Tomonari, Akio Katanuma, Tomoaki Matsumori, Hajime Yamazaki, Itsuki Sano, Ryuki Minami, Manabu Senyo, Satoshi Ikarashi, Kei Yane, Kuniyuki Takahashi
    Abstract:

    Endoscopic ultrasonography-guided fine needle aspiration (EUS-FNA) is a useful and relatively safe tool for the diagnosis and staging of pancreatic cancer. However, there have recently been several reports of Tumor Seeding after EUS-FNA of adenocarcinomas. A 78-year-old man was admitted to our hospital due to upper gastric pain. Examinations revealed a 20 mm mass in the pancreatic body, for which EUS-FNA was performed. The cytology of the lesion was adenocarcinoma, and the stage of the cancer was T3N0M0. The patient underwent surgery with curative intent, followed by adjuvant chemotherapy with S-1. An enlarging gastric submucosal Tumor was found on gastroscopy at 28 mo after surgery accompanied by a rising level of CA19-9. Biopsy result was adenocarcinoma, consistent with a pancreatic primary Tumor. Tumor Seeding after EUS-FNA was strongly suspected. The patient underwent surgical resection of the gastric Tumor with curative intent. The pathological result of the resected gastric specimen was adenocarcinoma with a perfectly matched mucin special stain result with the previously resected pancreatic cancer. This is the first case report of Tumor Seeding after EUS-FNA which was surgically resected and inspected pathologically.